Physician profile
Alyson Thomas
NPI 1992563951
$2,664.29
in general payments reported to CMS, 2019-2025
18 companies · $1,597 in 2025
The $1,597 reported for 2025 was more than what 89% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,067 · 2025: $1,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,652 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,652.14 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $634.83 | 2024-2025 | Caplyta |
| Alkermes, INC. | $439.40 | 2024-2025 | Aristada, Lybalvi, Aristada Initio |
| Abbvie INC. | $426.41 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $301.36 | 2024-2025 | Invega Sustenna, Spravato |
| Teva Pharmaceuticals USA, INC. | $195.70 | 2024-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $148.67 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Axsome Therapeutics, INC. | $130.05 | 2024-2025 | Auvelity |
| Lundbeck LLC | $107.14 | 2024-2025 | Rexulti |
| Indivior INC. | $39.22 | 2024-2025 | Sublocade, Perseris |
| Collegium Pharmaceutical, INC. | $38.33 | 2025 | Jornay Pm |
| Seqirus USA INC | $37.56 | 2024 | Flucelvax, Fluad |
| Corium, LLC | $31.67 | 2025 | Azstarys |
| Novo Nordisk INC | $29.98 | 2025 | Ozempic, Rybelsus |
| Biogen, INC. | $25.27 | 2025 | Zurzuvae |
| Medtronic, INC. | $24.91 | 2025 | Minimed 780g |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $20.61 | 2024 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $17.93 | 2025 | Cobenfy |
| Exact Sciences Corporation | $15.25 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.